Preventive genetic test against androgenetic alopecia

ALOPECIAgen targets the androgen receptor and 3 other polymorphisms implicated in the development of androgenetic alopecia. The ALOPECIAgen profile analyzes and allows distinguishing between three different risk groups before the appearance of any symptoms. Depending on the risk and the gender, a treatment with minoxidil and/or finasteride may be recommended. Other nutrigenetic and lifestyle recommendations given in the profile may contribute to the prevention of androgenetic alopecia.

When to prescribe?
  • In case alopecia exists in family history
  • Between the ages 20 to 30


Size:1.2 MBytes
Consent Form
Size:49 KBytes
Order Form
Size:168 KBytes
Size:258 KBytes